Compare that to sublingual delivery, which research suggests can achieve bioavailability potentially reaching 40% under optimal conditions
Safety profiles for once-weekly Ozempic (semaglutide) injection and once-daily Ozempic pill (semaglutide) injection and once-daily Ozempic pill Safety and tolerability evaluated across clinical trials Rates of GI symptoms across placebo-controlled trials with Ozempic injection and semaglutide tablets 1,2,a The most common adverse reactions reported in 5% of patients taking Ozempic injection and Ozempic tablets are nausea, vomiting, diarrhea, abdominal pain, and constipation
The gastrointestinal tract is learning to function with slower emptying times, and the nervous system is recalibrating its expectations about how quickly food should move through the digestive system
We physicians always want more than one therapy because not everyone responds 100% to any treatment
Counsel patients to report symptoms of thyroid tumors (e.g., a lump in the neck, hoarseness, dysphagia, or dyspnea) to their physician [see Boxed Warning, Warnings and Precautions (5.1)]
Important safety information: Mounjaro (tirzepatide) and Wegovy (semaglutide) are prescription-only medications for managing obesity and type 2 diabetes